Research Topics
| C U CorrellSummaryAffiliation: Long Island Jewish Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomesChristoph U Correll
The Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY 11004, USA
J Am Acad Child Adolesc Psychiatry 47:9-20. 2008
Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodromeChristoph U Correll
Albert Einstein College of Medicine, Department of Psychiatry, Bronx, NY, USA
Schizophr Bull 33:703-14. 2007..The presence and specificity of a bipolar prodrome remains questioned. We aimed to characterize the prodrome prior to a first psychotic and nonpsychotic mania and to examine the phenotypic proximity to the schizophrenia prodrome...
Balancing efficacy and safety in treatment with antipsychoticsChristoph U Correll
Recognition and Prevention Program, Zucker Hillside Hospital, Queens, New York, USA
CNS Spectr 12:12-20, 35. 2007....
Real-life dosing with second-generation antipsychoticsChristoph U Correll
The Zucker Hillside Hospital, 75-59 263rd Street, Glen Oaks, NY 11004, USA
J Clin Psychiatry 66:1610-1. 2005
Tardive dyskinesia and new antipsychoticsChristoph U Correll
The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
Curr Opin Psychiatry 21:151-6. 2008..To provide an update on tardive dyskinesia rates in patients treated with first-generation or second-generation antipsychotics in studies published since the last systematic review in 2004...
Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practiceChristoph U Correll
The Zucker Hillside Hospital, Division of Psychiatry Research, North Shore LIJ Health System, 75 59, 263rd Street, Glen Oaks, NY 11004, USA
Psychiatr Clin North Am 35:661-81. 2012....
Cost of antipsychotic polypharmacy in the treatment of schizophreniaBaojin Zhu
Eli Lilly and Company, Indianapolis, Indiana, USA
BMC Psychiatry 8:19. 2008..This study compared the costs of antipsychotic polypharmacy for patients who initiated on 1 of the 3 most commonly prescribed atypical antipsychotics - olanzapine, quetiapine, or risperidone...
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychoticsDouglas Faries
Outcomes Research, Eli Lilly and Company, Indianapolis, Indiana, USA
BMC Psychiatry 5:26. 2005..This study assessed the annual rate and duration of antipsychotic monotherapy and its inverse, antipsychotic polypharmacy, among schizophrenia patients initiated on commonly used atypical antipsychotic medications...
Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychoticsChristoph U Correll
Division of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
J Clin Psychiatry 72:655-70. 2011....
Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard?Christoph U Correll
Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
J Clin Psychiatry 69:578-83. 2008..The study was performed in patients receiving second-generation antipsychotics (SGAs), a medication class associated with CHD risk...
Individualizing antipsychotic treatment selection in schizophrenia: characteristics of empirically derived patient subgroupsC U Correll
The Zucker Hillside Hospital Center for Translational Psychiatry, The Feinstein Institute for Medical Research, Glen Oaks, USA
Eur Psychiatry 26:3-16. 2011..7%). The presence of these subgroups, which require confirmation and extension regarding potentially identifiable biological markers, may help individualizing treatment in patients with schizophrenia...
Early identification and high-risk strategies for bipolar disorderChristoph U Correll
The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
Bipolar Disord 9:324-38. 2007..To describe and compare the relative merits of different identification strategies for individuals at risk for bipolar disorder (BPD)...
Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behaviorChristoph U Correll
The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
Schizophr Res 131:58-62. 2011..Although common in psychiatric practice, reasons for antipsychotic polypharmacy (APP) have remained unclear...
Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trialsChristoph U Correll
Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
J Am Acad Child Adolesc Psychiatry 46:687-700. 2007..To review weight and metabolic effects of mood-stabilizing treatments in pediatric bipolar disorder...
One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic reviewChristoph U Correll
The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
J Child Adolesc Psychopharmacol 17:647-56. 2007..The aim of this study was to assess the 1-year risk of second-generation antipsychotics (SGAs) for tardive dyskinesia (TD) in children and adolescents with assumed minimal past exposure to first-generation antipsychotics...
Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trialsChristoph U Correll
The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
Bipolar Disord 12:116-41. 2010..To compare antipsychotic and mood stabilizer (MS) efficacy and tolerability in youth and adults with bipolar mania...
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescentsChristoph U Correll
Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, 75 59 263rd St, Glen Oaks, NY 11004, USA
JAMA 302:1765-73. 2009..Cardiometabolic effects of second-generation antipsychotic medications are concerning but have not been sufficiently studied in pediatric and adolescent patients naive to antipsychotic medication...
Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychoticsChristoph U Correll
The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
Bipolar Disord 10:788-97. 2008..We compared bipolar disorder and schizophrenia patients receiving SGAs to determine whether MetS prevalence is influenced by the primary psychiatric diagnosis or concomitant mood stabilizer treatment...
Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophreniaChristoph U Correll
The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
J Child Adolesc Psychopharmacol 18:475-90. 2008....
From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychoticsC U Correll
The Zucker Hillside Hospital, Psychiatry Research, 75 59 263rd Street, Glen Oaks, NY 11004, USA
Eur Psychiatry 25:S12-21. 2010..To optimize outcomes, antipsychotic treatment should be pharmacologically informed and measurement based, combining both acute and long-term management goals and balancing efficacy and adverse effect considerations...
Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatientsChristoph U Correll
Psychiatry Research Division, Zucker Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, NY 11004, USA
Psychiatr Serv 61:892-8. 2010..A national cardiometabolic screening program for patients in a variety of public mental health facilities, group practices, and community behavioral health clinics was funded by Pfizer Inc. between 2005 and 2008...
Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trialsChristoph U Correll
The Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, New York, NY 11004, USA
Schizophr Bull 35:443-57. 2009..Despite lacking evidence for its safety and efficacy, antipsychotic cotreatment is common in schizophrenia. Objective: To evaluate therapeutic and adverse effects of antipsychotic cotreatment vs monotherapy in schizophrenia...
Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patientsChristoph U Correll
Zucker Hillside Hospital, North Shore Long Island Jewish Health System Glen Oaks, New York 11004, USA
Int Rev Psychiatry 20:195-201. 2008..Research is required to elucidate risk factors, mechanisms and best interventions for antipsychotic related adverse endocrine and metabolic effects in pediatric patients...
Understanding schizoaffective disorder: from psychobiology to psychosocial functioningChristoph U Correll
Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
J Clin Psychiatry 71:8-13. 2010..These data, although inconclusive, contribute to clinicians' understanding of the etiology of the disorder. Further research may lead to an increased understanding of the disorder, improved treatment, and, ultimately, better outcomes...
Prospective study of adolescents with subsyndromal psychosis: characteristics and outcomeChristoph U Correll
The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
J Child Adolesc Psychopharmacol 15:418-33. 2005..The aim of this study was to examine the characteristics and outcome of adolescents with psychotic disorder not otherwise specified (PsyNOS) and brief psychotic disorder (BrPsy), two neglected subsyndromal diagnostic entities...
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studiesChristoph U Correll
Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Schneider Children s Hospital, Glen Oaks, NY 11004, USA
Am J Psychiatry 161:414-25. 2004..This hypothesis was examined in a systematic review of studies involving open or controlled treatment with any second-generation antipsychotic...
Research in people with psychosis risk syndrome: a review of the current evidence and future directionsChristoph U Correll
The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
J Child Psychol Psychiatry 51:390-431. 2010..While the research conducted to date has already yielded crucial information, the translation of the concept of a clinically identifiable PRS into clinical practice does not seem justified at this point...
Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?Christoph U Correll
The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
J Clin Psychiatry 66:1331-2. 2005
Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescentsChristoph U Correll
The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
Child Adolesc Psychiatr Clin N Am 15:177-206. 2006..This article presents an overview of SGA-related side effects in children and adolescents and strategies to monitor health outcomes effectively in youngsters receiving SGAs...
What are we looking for in new antipsychotics?Christoph U Correll
The Zucker Hillside Hospital, Psychiatry Research, 75 59 263rd St, Glen Oaks, NY 11004, USA
J Clin Psychiatry 72:9-13. 2011..It is hoped that research on drug-specific biomarkers that can predict response in specific patient groups will advance personalized psychiatric care and improve patient outcomes...
Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescentsChristoph U Correll
Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
J Clin Psychiatry 69:26-36. 2008....
Endocrine and metabolic adverse effects of psychotropic medications in children and adolescentsChristoph U Correll
The Zucker Hillside Hospital, Psychiatry Research, 75 59 263rd Street, Glen Oaks, NY 11004, USA
J Am Acad Child Adolesc Psychiatry 45:771-91. 2006..Endocrine and metabolic adverse effects are among the most concerning adverse effects of commonly used psychotropic medications...
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?Christoph U Correll
The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, United States
Schizophr Res 89:91-100. 2007..To determine whether the coprescribing of two or more antipsychotics, a relatively frequent practice with little data to support its safety and efficacy, is associated with an increased prevalence of metabolic syndrome...
Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternativesChristoph U Correll
The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
Dialogues Clin Neurosci 13:155-72. 2011....
Early prediction of antipsychotic response in schizophreniaChristoph U Correll
Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
Am J Psychiatry 160:2063-5. 2003..The authors' goal was to examine the predictive value of early symptom changes indicating response to antipsychotic medication in schizophrenia...
Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugsChristoph U Correll
The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY 11004, USA
J Clin Psychiatry 67:575-83. 2006....
Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medicationsDavid Straker
Department of Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY, USA
Am J Psychiatry 162:1217-21. 2005..The authors' goal was to explore the relationship between second-generation antipsychotics and the metabolic syndrome...
Metabolic effects of treatment with atypical antipsychoticsJohn M Kane
Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, USA
J Clin Psychiatry 65:1447-55. 2004
Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of SchizophreniaHenry A Nasrallah
Department of Psychiatry, University of Cincinnati College of Medicine, 260 Stetson St, Suite 3224, Cincinnati, OH 45267 0559, USA
J Clin Psychiatry 70:4-46. 2009..Summit faculty member opinion is compared with field survey results, and recommendations are made for future research...
Frequency and correlates of inappropriate pediatric psychiatric emergency room visitsErin Callahan Soto
Columbia University Medical Center, New York, New York, USA
J Clin Psychiatry 70:1164-77. 2009..Despite increasing pediatric psychiatric emergency room service (PPERS) visits, data are lacking regarding visit characteristics and appropriateness...
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapyJohn M Kane
Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY 11004 1150, USA
J Clin Psychiatry 70:1348-57. 2009..Combining antipsychotics is common practice in the treatment of schizophrenia. This study investigated aripiprazole adjunctive to risperidone or quetiapine for treating schizophrenia and schizoaffective disorder...
Pharmacologic treatment of schizophreniaJohn M Kane
Zucker Hillside Hospital, 75 59 263rd Street, Glen Oaks, NY 11004, USA
Dialogues Clin Neurosci 12:345-57. 2010..Moreover, new treatment options are needed that affect nondopaminergic targets with relevance for symptom reduction, relapse prevention, enhanced efficacy for nonresponders, and reduced key adverse effects...
The schizophrenia prodrome revisited: a neurodevelopmental perspectiveBarbara A Cornblatt
Albert Einstein College of Medicine, Bronx, NY, USA
Schizophr Bull 29:633-51. 2003..We conclude that a neurodevelopmental model of schizophrenia is supported by our data and that a range of novel treatment strategies may be neuroprotective by directly affecting the disorder's vulnerability core...
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trialsJohn M Kane
The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
J Psychopharmacol 24:1019-29. 2010..In conclusion, akathisia with aripiprazole occurred early in treatment, was mild-to-moderate in severity, led to few study discontinuations, and did not compromise therapeutic efficacy...
The assessment of "prodromal schizophrenia": unresolved issues and future directionsTodd Lencz
Albert Einstein College of Medicine, Bronx, NY, USA
Schizophr Bull 29:717-28. 2003..The dimensional quantification of prodromal symptom severity may be an important direction for future studies of the assessment of at-risk states...
Treatment models and designs for intervention research during the psychotic prodromeJohn M Kane
The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
Schizophr Bull 29:747-56. 2003..Finally, the methodology of completed and ongoing intervention trials in putative prodromal populations is discussed...
Predictors of insulin resistance in the obese with metabolic syndromePeter Manu
The Zucker Hillside Hospital, 59 75 263rd Street, Glen Oaks, NY 11004, USA
Eur J Intern Med 21:409-13. 2010..In the obese, the metabolic syndrome (MetS) is assumed to reflect insulin resistance...
Real-life switching strategies with second-generation antipsychoticsChristoph U Correll
The Zucker Hillside Hospital, 75-59 263rd Street, Glen Oaks, NY 11004, USA
J Clin Psychiatry 67:160-1. 2006
Genomics and the future of pharmacotherapy in psychiatryAnil K Malhotra
Division of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
Int Rev Psychiatry 19:523-30. 2007..These increasingly comprehensive approaches should provide informative data on the genes associated with psychotropic drug response, a critical step towards the ultimate goal of 'personalized' medicine...
A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agentsEma Saito
Department of Psychiatry Research, The Zucker Hillside Hospital, Long Island Jewish Medical Center, New Hyde Park, NY, USA
J Child Adolesc Psychopharmacol 14:350-8. 2004..We hypothesized: (1) risperidone would be associated with hyperprolactinemia most frequently, and (2) postpubertal females may be at higher risk of prolactin elevation and associated adverse effects...
Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophreniaTodd Lencz
Recognition and Prevention Program, Lake Success, NY 11042, USA
Schizophr Res 68:37-48. 2004....
Past and present progress in the pharmacologic treatment of schizophreniaJohn M Kane
Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
J Clin Psychiatry 71:1115-24. 2010....
Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescentsBarbara A Cornblatt
Recognition and Prevention RAP Program, Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
J Clin Psychiatry 68:546-57. 2007..This study reports the results of a prospective, naturalistic treatment study of adolescents considered to be in the prodromal (i.e., prepsychotic) phase of schizophrenia...
Symptomatic presentation and initial treatment for schizophrenia in children and adolescentsChristoph U Correll
Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, USA
J Clin Psychiatry 71:e29. 2010..Treatment regimens that include both pharmacotherapy and psychosocial interventions are needed to comprehensively treat children and adolescents with schizophrenia...
Pharmacogenetics of antipsychotic-induced weight gainChristoph U Correll
Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
Psychopharmacology (Berl) 174:477-89. 2004..To enhance power, future studies should pay close attention to population selection and avoidance/control of confounds, particularly past treatment exposure...
Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionalityJulie B Penzner
NewYork Presbyterian Hospital Weill Cornell Medical College, New York, New York, USA
J Child Adolesc Psychopharmacol 19:563-73. 2009..Although stimulants have opposing dopamine receptor and adverse effects, it is unclear whether stimulant co-treatment counteracts the therapeutic or side effects of antipsychotics...
Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: missed targets and lost opportunitiesChristoph U Correll
The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY, USA
Schizophr Res 92:103-7. 2007..Lowering low-density lipoprotein-cholesterol (LDL-C) to individualized targets of 100, 130 or 160 mg/dl reduces the risk of CHD. We determined the prevalence of above-target LDL-C and its management during psychiatric hospitalization...
Effect of hyperprolactinemia during development in children and adolescentsChristoph U Correll
Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks
J Clin Psychiatry 69:e24. 2008..Clinicians may need to employ pharmacotherapeutic interventions such as reducing dosage, switching antipsychotics, or prescribing adjunctive agents to minimize or prevent these negative side effects and improve patients' outcomes...
Antipsychotic polypharmacy, Part 2: Why use 2 antipsychotics when 1 is not good enough?Christoph U Correll
Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY, USA
J Clin Psychiatry 69:860-1. 2008
Antipsychotic polypharmacy, part 1: Shotgun approach or targeted cotreatment?Christoph U Correll
Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY, USA
J Clin Psychiatry 69:674-5. 2008
The QTc interval and its dispersion in patients receiving two atypical antipsychoticsChristoph U Correll
Medical Services, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
Eur Arch Psychiatry Clin Neurosci 259:23-7. 2009..Polytherapy with atypical antipsychotics is becoming common, but the effect of this practice on the QTc has not been explored in detail...
Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysisLawrence Maayan
Child Study Center, New York University School of Medicine, New York, NY, USA
Neuropsychopharmacology 35:1520-30. 2010..Antipsychotics with no or minimal cardiometabolic liability, as well as interventions that prevent or normalize adverse antipsychotic cardiometabolic effects are needed...
Clinical psychopharmacology of pediatric mood stabilizer and antipsychotic treatment, part 1: challenges and developmentsChristoph U Correll
The Zucker Hillside Hospital, Glen Oaks
J Clin Psychiatry 68:1301-2. 2007
Determination of plasma ziprasidone using liquid chromatography with fluorescence detectionRaymond F Suckow
Analytical Psychopharmacology Laboratory, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
J Chromatogr B Analyt Technol Biomed Life Sci 799:201-8. 2004..The utility of the method is exemplified with the presentation of clinical data from patients receiving ziprasidone...
Management of antipsychotic-related weight gainLawrence Maayan
Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA
Expert Rev Neurother 10:1175-200. 2010..Future research should focus on combining treatment modalities or agents and on exploring novel mechanism-based interventions...
Acute and long-term adverse effects of antipsychoticsChristoph U Correll
Albert Einstein College of Medicine, Bronx, New York, USA
CNS Spectr 12:10-4. 2007
Strategies for dosing and switching antipsychotics for optimal clinical managementPeter F Buckley
Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
J Clin Psychiatry 69:4-17. 2008....
Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparisonSanjiv Kumra
Department of Child and Adolescent Psychiatry, University of Minnesota, Minneapolis, Minnesota 55454 1495, USA
Biol Psychiatry 63:524-9. 2008..The present study evaluated the effectiveness and safety of clozapine versus "high-dose" olanzapine in treatment-refractory adolescents with schizophrenia...
Pharmacological management of bipolar disorder in a youth with diabetesMelissa P DelBello
University of Cincinnati College of Medicine, USA
J Am Acad Child Adolesc Psychiatry 46:1375-9. 2007
First-episode psychosis: a window of opportunity for best practicesPeter F Buckley
Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA, USA
CNS Spectr 12:1-12; discussion 13-4; quiz 15-6. 2007..The use of first- or second-generation antipsychotics for psychosis treatment, dosing guidelines, and the antipsychotic side-effect profile will also be addressed...
Paroxetine in the treatment of adolescent major depressionChristoph U Correll
J Am Acad Child Adolesc Psychiatry 41:1269; author reply 1270. 2002
Research Grants
- 3/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)Christoph U Correll; Fiscal Year: 2010..The results of this project will inform future treatment for children and adolescents with major psychiatric disorders. The results are also likely to lead to treatments that improve their health and longevity. ..
